source
- Pfizer shuts India cancer drug plant for up to two years, worsening drug shortagesPfizer has temporarily closed a manufacturing site in India that produces several cancer medicines. The company says the facility will remain idle for as long as two years while it addresses the i…
- Biogen posts third consecutive quarter of revenue growth, driven by Leqembi, Spinraza and Apellis productsBiogen reported $2.8 billion in revenue for the third quarter, marking its third straight period of top‑line growth. The company credited its growth portfolio, led by the Alzheimer’s therapy Leqem…